Kirjoita osake tai kryptovaluutta hakupalkkiin saadaksesi yhteenvedon
Royalty Pharma Plc
RPRXRoyalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 commercial products and 14 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neuroscience, immunology, respiratory, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York. Address: 110 East 59th Street, New York, NY, United States, 10022
Analytics
WallStreetin tavoitehinta
44.83 USDP/E-suhde
18.1133Osinkotuotto
3.06 %Kuluva vuosi
Edellinen vuosi
Nykyinen vuosineljännes
Viimeinen vuosineljännes
Kuluva vuosi
Edellinen vuosi
Nykyinen vuosineljännes
Viimeinen vuosineljännes
Avainluvut RPRX
Osinkoanalytiikka RPRX
Osinkojen kasvu 5 vuoden aikana
–Jatkuva kasvu
3 vuottaMaksusuhde 5 vuoden keskiarvo
279 %Osinkohistoria RPRX
Osakkeen arvostus RPRX
Talousasiat RPRX
Tuloksia | 2019 | Dynamiikka |